UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

~~February~~May 41, 2025

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

Delaware	001-32431	90-0199783
(State or other jurisdictionof incorporation)	(CommissionFile Number)	(IRS Employer Identification No.)
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1275 Market Street

San Francisco, CA 94103-1410

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A common stock, $0.001 par value	DLB	The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~Item~~Section 2 ~~5.03.~~– ~~Amendments~~Financial toInformation ~~Articles of Incorporation or Bylaws; Change in Fiscal Year.~~

AtITEM ~~the Dolby Laboratories, Inc~~2.02 ~~(the~~Results ~~“Company”) 2025 Annual Meeting~~ of ~~Stockholders~~Operations ~~(the “Annual Meeting”), held on February 4, 2025 via live webcast, the Company’s stockholders approved an amendment to the Company’s Amended~~ and ~~Restated~~Financial ~~Certificate of Incorporation to provide for the exculpation of certain of the Company’s officers from liability in specific circumstances, as permitted by Delaware law (the “Charter Amendment”)~~Condition. A description of the Charter Amendment was set forth in the Company’s definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (the “SEC”) on December 20, 2024. The Charter Amendment became effective upon the filing of a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware on February 5, 2025 (the “Certificate of Amendment”).

The ~~foregoing~~following ~~description~~information ofis ~~the~~intended ~~Charter~~to ~~Amendment~~be ~~does~~furnished ~~not~~under ~~purport~~Item to2.02 beof ~~complete~~Form 8-K, “Results of Operations and isFinancial ~~qualified~~Condition.” inThis ~~its~~information ~~entirety~~shall bynot ~~reference~~be todeemed ~~the~~“filed” ~~full~~for ~~text~~purposes of Section 18 of the ~~Certificate~~Securities Exchange Act of ~~Amendment~~1934, aas ~~copy~~amended of(the ~~which~~“Exchange isAct”), ~~filed~~or asincorporated ~~Exhibit~~by ~~3.1~~reference toin ~~this~~any ~~Current~~filing ~~Report~~under onthe ~~Form~~Securities ~~8-K~~Act ~~and~~of is1933, ~~incorporated~~as ~~herein~~amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

~~Item~~On 5May 1, 2025, Dolby Laboratories, Inc.07 (the “Company”) issued a press release announcing its financial results for its fiscal quarter ended March 28, 2025. ~~Submission~~The full text of ~~Matters~~the topress arelease ~~Vote~~is offurnished ~~Security~~as ~~Holders~~Exhibit 99.1 and is incorporated herein by reference.

~~5.07(a)~~Section 8 ~~and~~– ~~(b)~~Other Events

~~The~~ITEM ~~information set forth in Item 5~~8.0301 ~~above~~Other ~~is incorporated by reference herein. At the Annual Meeting, the Company’s stockholders:~~ Events

1.Declaration ~~Elected eight directors to serve until the 2026 Annual Meeting~~ of ~~Stockholders~~Dividend ~~or until their successors are duly elected and qualified;~~

2On May 1, 2025, the Company announced a cash dividend of $0.33 ~~Approved~~per anshare ~~advisory~~of ~~vote~~Class A and Class B Common Stock, payable on May 21, 2025 to ~~approve~~stockholders ~~the~~of ~~compensation~~record as of the ~~Company’s~~close ~~named~~of ~~executive~~business ~~officers;~~on May 13, 2025.

3.Disclosure ~~Approved,~~Channels ~~on an advisory basis, one year as the frequency of holding future advisory votes~~ to ~~approve~~Disseminate ~~named~~Information ~~executive officer compensation;~~

4The Company disseminates information to the public about the Company, its products, services and other matters through various channels, including the Company’s website (www.dolby.com), ~~Approved~~investor relations website (http://investor.dolby.com), SEC filings, press releases, public conference calls and webcasts, in order to achieve broad, non-exclusionary distribution of information to the ~~Charter~~public. ~~Amendment;~~The Company encourages investors and others to review the information it makes public through these channels, as such information could be deemed to be material information.

5.Section 9 ~~Ratified~~– ~~the~~Financial ~~appointment~~Statements ofand ~~KPMG~~Exhibits ~~LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 26, 2025.~~

~~Each~~ITEM share of the Company’s Class A common stock is entitled to one vote, and each share of the Company’s Class B common stock is entitled to ten votes, on all matters submitted to a vote of stockholders at the Annual Meeting9.01 ~~The~~Financial ~~Class A~~Statements ~~common stock~~ and ~~Class B common stock vote together as a single class on all matters submitted to a vote of stockholders, except as may otherwise be required by law~~Exhibits. ~~At the Annual Meeting, the holders of Class A common stock and Class B common stock voted as follows:~~

Proposal 1 - Election of directors:

Director	Votes For	Votes Withheld	Broker Non-Votes
Kevin Yeaman	401,881,678	1,531,011	3,907,283
Peter Gotcher	376,131,026	27,281,663	3,907,283
David Dolby	383,437,903	19,974,786	3,907,283
Tony Prophet	402,176,649	1,236,040	3,907,283
Emily Rollins	402,157,515	1,255,174	3,907,283
Simon Segars	382,967,153	20,445,536	3,907,283
Anjali Sud	401,042,318	2,370,371	3,907,283
Avadis Tevanian, Jr.	382,227,407	21,185,282	3,907,283

All director nominees were duly elected.

Proposal 2 - Approval of an advisory vote to approve the compensation of the Company’s named executive officers:

Votes For		Votes Against		Abstentions		Broker Non-Votes
400,557,293		2,791,215		64,182		3,907,283

Proposal 2 was approved.

Proposal 3 – Approval of an advisory vote on the frequency of future advisory votes to approve named executive officer compensation:

1 Year		2 Years		3 Years		Abstentions		Broker Non-Votes
402,427,139		24,550		913,914		47,086		3,907,283

A frequency of one year was approved.

Proposal 4 - Approval of the Charter Amendment:

Votes For		Votes Against		Abstentions		Broker Non-Votes
367,830,455		35,533,332		48,901		3,907,283

Proposal 4 was approved.

Proposal 5 - Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 26, 2025:

Votes For		Votes Against		Abstentions
405,989,852		1,275,349		54,771

Proposal 5 was approved.

5.07(d)

In accordance with the recommendation of the Company’s Board of Directors, the Company’s stockholders approved, on an advisory basis, one year as the frequency for holding future advisory votes to approve the compensation of the Company’s named executive officers. In light of such approval, the Company intends to hold an advisory vote on the compensation of the Company’s named executive officers on an annual basis until the next required vote on the frequency of holding an advisory vote to approve named executive officer compensation.

Section 9 - Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

ExhibitNo.		Description
3.1		Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Dolby Laboratories, Inc.
99.1		Press Release of Dolby Laboratories, Inc. dated May 1, 2025
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DOLBY LABORATORIES, INC. By: /s/ ~~ANDY~~Robert ~~SHERMAN~~Park ~~Andy~~Robert ~~Sherman~~Park ~~Executive~~Senior Vice President, ~~General~~and ~~Counsel~~Chief ~~and~~Financial ~~Corporate~~Officer ~~Secretary~~(Principal Financial Officer)

Date: ~~February~~May 71, 2025

Filing Compare · Dolby Laboratories, Inc.